Skip to main content
. 2020 Mar 11;29(7):1154–1167. doi: 10.1093/hmg/ddaa033

Table 1.

Information about differentially methylated sites (DMSs) that showed significant correlation with gene expression and association with nearby SNPs

CpG site Gene Methylation changes Gene expression changes mQTL analysis
methylation difference (adjusted P-value) correlation coefficient (adjusted P-value) mQTL-SNP maximum methylation difference (adjusted P-value)
discovery replication
chr14.24801071 ADCY4* −0.17 (6.60e−03) −0.17 (1.44e−02) −0.40 (2.15e−04) rs11158632 0.18 (2.75e-02)
chr14.24801073 ADCY4* −0.17 (4.00e−02) −0.19 (2.50e−02) −0.29 (1.28e−02) rs12891732 0.15 (1.29e-02)
chr10.49673509 ARHGAP22* −0.11 (6.52e−03) −0.09 (3.74e−03) −0.32 (4.25e−03) rs9663790 0.12 (1.14e-02)
chr6.91007306 BACH2* −0.13 (8.67e−03) −0.10 (6.24e−03) 0.32 (4.60e−03) rs2174281 0.14 (4.39e-02)
chr1.95393371 CNN3* −0.18 (1.47e−03) −0.11 (3.80e−03) 0.33 (2.72e−03) rs859057 0.02 (1.91e-02)
chr17.56004243 CUEDC1* −0.09 (9.65e−05) −0.05 (1.58e−03) −0.38 (4.15e−04) rs1017528 0.11 (4.15e-02)
chr19.45930589 ERCC1* −0.14 (1.84e−10) −0.05 (1.79e−02) −0.32 (3.29e−03) rs11615 0.14 (3.07e-02)
chr21.40176597 ETS2* −0.17 (1.02e−03) −0.10 (9.91e−04) 0.24 (4.10e−02) rs2283639 0.39 (3.23e-11)
chr11.61596996 FADS2 −0.17 (1.61e−02) −0.14 (2.44e−02) −0.32 (6.24e−03) rs174535 0.23 (7.59e-03)
chr6.150040098 LATS1 −0.22 (8.28e−09) −0.11 (2.27e−04) 0.44 (4.23e−05) rs10872646 0.24 (3.79e-02)
chr5.169694956 LCP2* −0.12 (2.58e−04) −0.05 (4.01e−02) 0.30 (6.89e−03) rs2271146 0.18 (3.87e-03)
chr19.58513473 LOC100128398 0.08 (4.95e−02) 0.06 (1.26e−02) −0.33 (2.72e−03) rs11881126 0.14 (1.04e-03)
chr10.134166587 LRRC27* −0.10 (7.72e−05) −0.07 (7.98e−06) −0.31 (4.96e−03) rs2474339 0.08 (2.65e-02)
chr13.113656361 MCF2L* −0.23 (3.74e−05) −0.21 (3.72e−02) 0.39 (3.26e−04) rs2993282 0.25 (3.55e-02)
chr19.45351770 PVRL2 −0.18 (1.10e−05) −0.06 (1.32e−02) −0.42 (9.53e−05) rs2075642 0.20 (8.22e-03)
chr19.45351779 PVRL2 −0.21 (1.81e−07) −0.12 (3.44e−03) −0.39 (2.15e−04) rs395908 0.12 (3.79e-02)
chr19.45352168 PVRL2 −0.14 (2.62e−02) −0.15 (1.46e−05) −0.26 (2.39e−02) rs4803760 0.36 (1.59e-03)
chr15.67430536 SMAD3* −0.07 (8.35e−04) −0.09 (8.13e−04) 0.39 (2.15e−04) rs1065080 0.04 (5.34e-03)
chr22.39147165 SUN2 −0.11 (3.47e−02) −0.10 (1.71e−05) 0.39 (2.15e−04) rs4821822 0.07 (1.54e-02)
chr12.50136491 TMBIM6 −0.13 (8.59e−03) −0.10 (4.02e−02) 0.26 (2.95e−02) rs1993398 0.04 (1.29e-02)
chr17.10634582 TMEM220* −0.15 (1.11e−03) −0.13 (1.51e−03) 0.33 (2.87e−03) rs406446 0.19 (8.05e-03)
chr10.73062374 UNC5B −0.12 (1.66e−03) −0.04 (3.79e−03) −0.29 (1.19e−02) rs1538894 0.13 (5.45e-03)
chr6.30883001 VARS2* −0.14 (4.36e−03) −0.21 (3.96e−02) −0.26 (2.73e−02) rs2249459 0.23 (1.99e-02)
chr3.22412739 ZNF385D −0.19 (2.19e−03) −0.23 (9.34e−04) −0.28 (1.86e−02) rs9854991 0.22 (2.96e-02)

Genes are listed alphabetically, sites are sorted by genes; columns show adjusted P-values as well as the difference in mean methylation levels between old and young individuals in the discovery and replication cohort; Spearman’s correlation coefficient and maximum difference in median methylation levels between genotypes. * indicates genes for which a literature and database search ((28, 32–41); https://gemex.eurac.edu/bioinf/age/ (42)) yielded significant age-related expression changes.